The knockdown of MDH2 in prostate cancer cell lines decreased cell proliferation, increased sensitivity to the chemotherapy drug docetaxel, and affected signaling pathways and metabolic efficiency by influencing JNK signaling and oxidative metabolism (246). Here, MDH2 is linked to prostate cancer.